Institute of Endocrinology, Diabetes & Metabolism and Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, 49100, Petach Tikva, Israel.
School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Mol Biol Rep. 2024 Feb 11;51(1):297. doi: 10.1007/s11033-023-09186-7.
Erythropoietin-producing hepatocellular (EPH) receptors are the largest known family of receptor tyrosine kinases characterized in humans. These proteins are involved in tissue organization, synaptic plasticity, vascular development and the progression of various diseases including cancer. The Erythropoietin-producing hepatocellular receptor tyrosine kinase member EphB6 is a pseudokinase which has not attracted an equivalent amount of interest as its enzymatically-active counterparts. The aim of this study was to assess the expression of EphB6 in pituitary tumors.
Human normal pituitaries and pituitary tumors were examined for EphB6 mRNA expression using real-time PCR and for EphB6 protein by immunohistochemistry and Western blotting. EphB6 was highly expressed in non-functioning pituitary neuroendocrine tumors (NF-PitNETs) versus the normal pituitary and GH-secreting PitNETs. EphB6 mRNA expression was correlated with tumor size.
Our results suggest EphB6 aberrant expression in NF-PitNETs. Future studies are warranted to determine the role and significance of EphB6 in NF-PitNETs tumorigenesis.
促红细胞生成素产生肝细胞(EPH)受体是人类已知的最大的受体酪氨酸激酶家族。这些蛋白质参与组织构建、突触可塑性、血管发育以及各种疾病的进展,包括癌症。EPH 产生肝细胞受体酪氨酸激酶成员 EphB6 是一种伪激酶,其并未像具有酶活性的对应物那样引起同等程度的关注。本研究旨在评估 EphB6 在垂体肿瘤中的表达。
使用实时 PCR 检测人正常垂体和垂体肿瘤中的 EphB6 mRNA 表达,并通过免疫组织化学和 Western blot 检测 EphB6 蛋白。EphB6 在无功能垂体神经内分泌肿瘤(NF-PitNETs)中与正常垂体和 GH 分泌性 PitNETs 相比表达较高。EphB6 mRNA 表达与肿瘤大小相关。
我们的结果表明 EphB6 在 NF-PitNETs 中存在异常表达。未来的研究需要确定 EphB6 在 NF-PitNETs 肿瘤发生中的作用和意义。